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Abstract: A synthesis of () epipentenomycin I and III is reported from a regioselective epoxidation of 
racemic 3-hydroxy- and 3-acetoxy-2-methylene-4-cyclopentenone, respectively, with 
dimethyldioxirane followed by hydrolytic ring-opening of the resulting epoxide.   
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The pentenomycin group of natural products (compounds 1-4) have antibacterial activities against 
both Gram-positive and Gram-negative bacteria.  Pentenomycin I (1) and II (2) were first isolated from 
Streptomyces eurythermus in 19731 while pentenomycin III (3) was isolated three years later from 
Streptoverticillium eurocidicum.2  Epipentenomycin I (4), however, was isolated in 19893 from carpophores 
of Perziza sp., much later than its first synthesis in racemic form in 1980.4,5  Their biological activities and 
their highly oxygenated structures have attracted several synthetic studies on their total synthesis,6 the 
synthesis of their racemates4,5,7 and their analogues8 (e.g. epipentenomycin II (5) and III (6)).  We report here 
a diastereoselective synthesis of () epipentenomycin I (4) and III (6) from the diastereoselective epoxidation 
of 3-hydroxy- and 3-acetoxy-2-methylene-4-cyclopentenone, respectively, with dimethyldioxirane followed 









1; pentenomycin  (R1 = R2 = H)
2; pentenomycin  (R1 = Ac, R2 = H)
3; pentenomycin (R1 = H, R2 =Ac)
4; epipentenomycin  (R1 = R2 = H)
5; epipentenomycin  (R1 = Ac, R2 = H)
6; epipentenomycin (R1 = H, R2 =Ac)  
Treatment of freshly prepared 3-hydroxy-2-methylene-4-cyclopentenone (7)9 with freshly distilled 
dimethyldioxirane (DMDO) in acetone10 at RT for 12 h produced an 83 : 17 mixture of the anti- and syn-
epoxy-alcohols 8 and 9, respectively and the unexpected product 10.  The crude mixture was separated by 
flash chromatography to give diastereomerically pure 8 and 10 in yields of 49% and 36%, respectively.11 The 
syn-isomer 9 could not be isolated in pure form.  The structure of 8 was clear from spectral analysis, although 
its relative stereochemistry could only be deduced from its transformation into () epipentenomycin I (4).  The 
NMR spectra of compound 10 indicated the presence of an ethyl and an acetate group and its structure was 



































While the mechanism for the formation of 10 is not clear, this compound formally arises from the 
incorporation of one molecule of DMDO into 7 (Scheme 2).  Interestingly, both products 8 and 10 arise from 
addition of DMDO anti to the allylic hydroxyl group in 7. Our attempts to reverse the diastereoselectivity in 
favour of diastereomer 9, which should yield pentenomycin I after hydrolytic epoxide ring-opening, were 
unsuccessful.  The use of the less polar solvent CCl4 in this reaction, conditions that should favour 9 by 
enhancing H-bonding between the allylic hydroxyl group in 7 and DMDO,13 led to poorer overall yields due 















Figure 1. ORTEP plot of 10.  
Protic acid (H2SO4 or HClO4) or Lewis acid (BiCl3)
14 catalysed hydrolysis reactions of the epoxide ring of 
rac-8 to give () epipentenomycin I (4) were not clean and led to impure samples of the desired product.  
However, heating a solution of rac-8 in D2O
15 solution in an NMR tube at 80 oC, with monitoring by 1H NMR 
spectroscopy, cleanly led to ring-opening of the epoxide group. After freeze-drying pure () epipentenomycin 
I (4) was obtained in 74% yield (Scheme 1).  This sample had identical spectral characteristics to those 
reported in the literature for this compound.7a  
In an attempt to prepare () epipentenomycin II (5) we acetylated the known alcohols rac-11a and rac-11b, to 
give their respective allylic acetates, rac-12a and rac-12b   These compounds were highly crystalline and their 
relative stereochemistries were secured by single-crystal X-ray studies.12  Treatment of the individual isomers 
rac-12a and rac-12b or a mixture of these isomers under flash vacuum pyrolysis (FVP) conditions gave the 
novel allylic acetate rac-13 in 78% yield.11 Treatment of rac-13 with freshly distilled DMDO in acetone at RT 
for 12 h produced an 80 : 20 mixture of the anti- and syn-epoxy-acetates, rac-14 and rac-15, respectively.  No 
product corresponding to the acetate derivative of 10 could be isolated.  Purification by flash chromatography 
gave an inseparable 80 : 20 mixture of  rac-14 and rac-15 in 42% yield.  Hydrolytic ring-opening of this 
mixture in D2O gave, as the major components from 
1H NMR analysis, about a 1 : 1 mixture of racemic 
epipentenomycins II and III formed from ring-opening of rac-14 and then migration of  the secondary acetate 
in rac-5 to the more stable primary position. Smith7a has demonstrated that in solution these isomeric acetates 
are in equilibrium and that chloroform solution favours the primary acetate isomer.  Thus this mixture was 
freeze-dried and purified by PTLC using dichloromethane as eluant to give about an 80 : 20 mixture of 
epipentenomycin III and a second isomer, albeit in modest yield (22%). These compounds had 1H NMR 
spectral data in CDCl3 that matched closely and were similar, respectively, to that reported for 
epipentenomycin III and pentenomycin III, respectively.7a 
In conclusion we have developed a synthesis of epipentenomycin I via a diastereoselective epoxidation of 7 
followed by mild hydrolysis of the resulting epoxide group.  We have also found a novel oxidation product, 
the compound 10, in this epoxidation reaction.  We are currently working on the synthesis of enantiomerically 

































rac-11a (R1 = H, R2 = OH)
rac-11b (R1 = OH, R2 = H)
rac-12a (R1 = H, R2 = OAc)
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